Cellular pathology of mitral valve prolapse

Cardiovasc Pathol. 2010 Jul-Aug;19(4):e113-7. doi: 10.1016/j.carpath.2009.03.002. Epub 2009 Apr 16.

Abstract

Background: Mitral valve prolapse (MVP) is the most frequent cause of chronic, pure, and isolated mitral regurgitation, and is estimated to affect more than 144 million individuals worldwide. This short review focuses in particular on the structural and cellular aspects of MVP in humans. The key microscopic change in MVP appears to occur in the fibrosa, on which the structural integrity of the entire valve depends. Recent discoveries showed that proteoglycans may play an active role in both MVP initiation and/or progression together with valvular interstitial cells. A full understanding of the cellular basis of MVP goes beyond a mere mechanicistic description of the disease, involving the transformation of resting fibroblasts into activated myofibroblasts.

Conclusions: Mitral valve could represent therefore an ideal environment to study early transformation phases of fibroblasts toward a protomyofibroblast phenotype.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Fibroblasts / cytology
  • Humans
  • Mitral Valve / metabolism
  • Mitral Valve / pathology*
  • Mitral Valve Prolapse / pathology*
  • Proteoglycans / metabolism

Substances

  • Proteoglycans